Sign in

CIK 0001590877 · Non-accelerated filer<br>Smaller reporting company

REGENXBIO Inc.

Sign in to watch
Ticker
RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
471851754
Phone
240-552-8181
Business address
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
Former names
ReGenX Biosciences, LLC
Open-market buys, last 90 days
$949,381
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Ciongoli Gregory Austin +$949K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-05-29 Tasse Daniel Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2020-05-29 STUMP DAVID C Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2020-05-29 KARABELAS ARGERIS N Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2020-05-29 HAYDEN DONALD J JR Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2020-05-29 Glucksmann Alexandra Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2020-05-29 Fox Allan M. Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2020-05-29 BESHAR LUKE M Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2020-05-29 Abdun-Nabi Daniel Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2020-05-11 Vasista Vittal Chief Financial Officer Option exercise +500 $13.09 $7K 207,215
2020-05-11 Vasista Vittal Chief Financial Officer Sale −500 $40.00 $20K 206,715
2020-05-11 Vasista Vittal Chief Financial Officer Option exercise · Employee Stock Option (Right to Buy) −500 17,374
2020-05-08 Vasista Vittal Chief Financial Officer Option exercise +2,500 $13.09 $33K 213,715
2020-05-08 Vasista Vittal Chief Financial Officer Sale −7,000 $40.18 $281K 206,715
2020-05-08 Vasista Vittal Chief Financial Officer Option exercise · Employee Stock Option (Right to Buy) −2,500 17,874
2020-04-24 Vasista Vittal Chief Financial Officer Option exercise +3,000 $13.09 $39K 223,215
2020-04-24 Vasista Vittal Chief Financial Officer Sale −12,000 $40.11 $481K 211,215
2020-04-24 Vasista Vittal Chief Financial Officer Option exercise · Employee Stock Option (Right to Buy) −3,000 20,374
2020-04-23 Vasista Vittal Chief Financial Officer Option exercise +3,000 $13.09 $39K 223,215
2020-04-23 Vasista Vittal Chief Financial Officer Sale −3,000 $40.00 $120K 220,215
2020-04-23 Vasista Vittal Chief Financial Officer Option exercise · Employee Stock Option (Right to Buy) −3,000 23,374

Page 22 of 25 · 494 trades